首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1435308

2024 年細胞化驗分析全球市場報告

Cell Based Assays Global Market Report 2024

出版日期: 按訂單生產 | 出版商:

The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄

細胞化驗分析的市場規模預計在未來幾年將快速成長。預計到 2028 年將以 11.7% 的複合年成長率 (CAGR) 成長至 418.6 億美元。預測期內的預期成長主要歸因於人工智慧和機器學習的整合、不斷變化的監管環境、對高內容篩檢的需求不斷增加、疾病建模的進步以及對精準醫療的關注。這段時期的主要趨勢包括高通量篩檢（HTS）的採用、3D細胞培養的使用、晶片上器官技術的實施、CRISPR/Cas9技術的應用以及成像技術的進步。

基於細胞的陣列在研究中的使用正在增加，因此需要在藥物發現中轉向更具預測性的細胞模型，以減少後期失敗。製藥業迫切需要有效地將藥物推向市場並減少代價高昂的後期失敗，這是細胞化驗分析創新的關鍵驅動力。新藥臨床實驗（IND）III期臨床試驗的失敗可能會為公司帶來高達數億美元的重大財務損失。 Sigma的報告顯示，考慮到目前的後期失敗率，製藥公司的收益可能會驟降至5%，這對大多數公司來說是不可接受的水平。高內涵系統和細胞化驗分析中資料分析的顯著增強使科學家能夠提取有關細胞反應的更多資訊，支持藥物發現中的明智決策，這將進一步推動基於陣列的市場的成長。

生技藥品銷售的預期成長將推動細胞化驗分析市場向前發展。生技藥品，包括生物來源藥物，如疫苗、血液成分、基因療法和治療性蛋白質，依靠細胞化驗分析來評估功能、功效、安全性和生物相似性。例如，2023年加拿大政府報告稱，2021年生技藥品銷售額超過110億美元。電子付款的普及也推動了細胞化驗分析市場的發展。

全球細胞化驗分析市場，按產品和服務細分、性能和預測，2018-2023、2023-2028、2033
消耗品
裝置
服務
軟體
全球細胞化驗分析市場，依技術細分，實際與預測，2018-2023、2023-2028、2033
自動處理
流式細胞技術
無標定檢測
高通量篩檢
其他技術
全球細胞化驗分析市場，按應用細分、實際和預測，2018-2023、2023-2028、2033
藥物發現
基礎調查
ADME研究
預測毒理學
其他用途
全球細胞化驗分析市場，按最終用戶細分，實際和預測，2018-2023、2023-2028、2033
製藥和生物技術公司
學術和政府研究機構
受託研究機構（CRO）
其他最終用戶

第 7 章區域與國家分析

全球細胞化驗分析市場，按地區、表現和預測，2018-2023、2023-2028、2033
全球細胞化驗分析市場，依國家、績效及預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章中國市場

第10章印度市場

第11章日本市場

第12章澳洲市場

第13章印尼市場

第14章韓國市場

第15章西歐市場

第16章英國市場

第17章德國市場

第18章法國市場

第19章義大利市場

第20章西班牙市場

第21章東歐市場

第22章俄羅斯市場

第23章北美市場

第24章美國市場

第25章加拿大市場

第26章南美洲市場

第27章巴西市場

第28章中東市場

第29章非洲市場

第30章競爭形勢及公司概況

細胞化驗分析市場的競爭形勢
細胞化驗分析市場公司概況
- F. Hoffmann-La Roche Ltd.
- Merck &Co. Inc.
- Thermo Fisher Scientific Inc.
- Danaher Corporation
- Becton, Dickinson and Company

第31章其他大型創新公司

GE HealthCare Technologies Inc.
Corning Incorporated
Lonza Group Ltd.
Charles River Laboratories International Inc.
PerkinElmer Inc.
Sigma-Aldrich Corporation
Bio-Rad Laboratories Inc.
Miltenyi Biotec GmbH
Abcam plc
BioVision Inc.
Promega Corporation
Caliper Life Sciences Inc.
Cell Signaling Technology Inc.
BioTek Instruments Inc.
Enzo Life Sciences Inc.

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章重大併購

第35章未來前景與可能性分析

第36章附錄

簡介目錄

Product Code: r15022

Cell-based assays are experimental tools designed for studying reactions occurring inside cells, allowing researchers to investigate various mechanisms and processes related to cellular function.

The main products and services associated with cell-based assays include consumables, instruments, services, and software. Consumables are items that are used up or depleted during their usage. Instruments commonly used in cell-based assays encompass microplates, microplate readers, high-throughput screening systems, and liquid handling systems. Various consumables essential for these assays include reagents and media, cells and cell lines, probes, and labels. Cell-based assays employ different technologies, such as automated handling, flow cytometry, label-free detection, high-throughput screening, among others. These assays find applications in drug discovery, basic research, ADME (Absorption, Distribution, Metabolism, and Excretion) studies, predictive toxicology, and other research purposes. End-users of cell-based assays include pharmaceutical and biotechnology companies, academic and government research institutes, contract research organizations (CROs), and others.

The cell-based assays market research report is one of a series of new reports from The Business Research Company that provides cell-based assays market statistics, including cell-based assays industry global market size, regional shares, competitors with a cell-based assays market share, detailed cell-based assays market segments, market trends, and opportunities, and any further data you may need to thrive in the cell-based assays industry. This cell-based assays market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cell based assays market size has grown strongly in recent years. It will grow from $24.61 billion in 2023 to $26.9 billion in 2024 at a compound annual growth rate (CAGR) of 9.3%. The growth observed during the historic period in the field of cell-based assays can be attributed to several factors, including the emergence of high-throughput screening (HTS) techniques, the integration of automation, the utilization of biomarker detection methods, the adoption of microfluidics, and the introduction of gene editing tools.

The cell based assays market size is expected to see rapid growth in the next few years. It will grow to $41.86 billion in 2028 at a compound annual growth rate (CAGR) of 11.7%. The growth expected in the forecast period is primarily due to the integration of AI and machine learning, a shift in the regulatory landscape, increased demand for high-content screening, advancements in disease modeling, and a focus on precision medicine. Key trends during this period include the adoption of high-throughput screening (HTS), the utilization of 3D cell cultures, the implementation of organ-on-a-chip technology, the application of CRISPR/Cas9 technology, and progress in imaging techniques.

The utilization of cell-based arrays in research is on the rise, necessitating a shift towards more predictive cellular models in drug discovery to mitigate last-stage failures. The pharmaceutical industry's imperative to effectively bring drugs to market and mitigate costly late-stage failures is a key driver in the innovation of cell-based assays. Failure in Phase III clinical trials of investigational new drugs (IND) can result in substantial financial losses, reaching several hundred million dollars for the company. Sigma's report indicates that the return on investment for pharmaceutical companies could plummet to 5% given the current rate of late-stage failures, an unacceptable level for most companies. Significant enhancements in high-content systems and data analysis in cell-based assays empower scientists to extract more information about cellular responses, aiding informed decision-making in drug discovery and further fueling the growth of the cell-based array market.

The anticipated increase in biologics sales is set to propel the cell-based assays market forward. Biologics, encompassing medicines derived from living organisms, including vaccines, blood components, gene therapies, and therapeutic proteins, rely on cell-based assays for evaluating functionality, potency, safety, and bio-similarity. For example, in 2023, the Government of Canada reported biologics sales exceeding $11 billion in 2021. The surge in electronic payment methods is also contributing to the drive in the cell-based assays market.

The primary factor constraining the global cell-based assay market is the high cost of instruments. The elevated prices of instrumentation can diminish the return on investments (ROI) due to low adaptation. Biotek's development of HCA (high content analysis) instruments, while advanced, comes with a high price tag, limiting accessibility to industrial end-users or core labs with sufficient capital budgets. This restriction prevents low-budget end-users from fully leveraging cell-based assays, thereby impeding market growth.

Researchers are increasingly leaning towards early-phase predictive toxicity testing to avert late-stage drug failures. The scaling up of predictive cell toxicity assays aims to increase compound screening in the early stages of drug development, reducing the cost of failure. For instance, Creative Bioarray, a biotech company, offers a range of in vitro toxicity services to assess drug-induced toxicities, saving time and costs by minimizing the risk of failure in earlier stages. These advancements aim to simplify clinical testing and reduce operational costs.

Leading companies in the cell-based assays market are introducing new platforms, such as cell-based phenotypic assay platforms, to provide advanced solutions for drug discovery. A cell-based phenotypic assay platform is a system in drug discovery that evaluates cellular responses to compound treatments by integrating advanced imaging and analytical tools, powered by artificial intelligence. In February 2021, Selvita, a Poland-based biotechnology company, launched a new cell-based phenotypic assay platform for drug discovery, targeting areas such as neuroinflammatory and fibrotic diseases. This advanced platform integrates high-content imaging systems with artificial intelligence to enhance drug profiling and mechanism of action studies, aiming to expedite the drug discovery process. The platform enhances Selvita's offerings for pharmaceutical and biotech companies looking to leverage AI in drug discovery.

In May 2022, Cell Carta, a Canada-based provider of precision medicine laboratory services, acquired next-generation immune-MRM assays from Precision Assays for an undisclosed amount. This acquisition aims to strengthen Cell Carta's position in the proteomics vertical and enhance its service offerings in precision medicine laboratory services. Precision Assays, a US-based provider of next-generation targeted proteomics testing solutions, played a significant role in this strategic move.

Major companies operating in the cell based assays market report are F. Hoffmann-La Roche Ltd., Merck & Co. Inc., Thermo Fisher Scientific Inc., Danaher Corporation, Becton, Dickinson and Company, GE HealthCare Technologies Inc., Corning Incorporated, Lonza Group Ltd., Charles River Laboratories International Inc., PerkinElmer Inc., Sigma-Aldrich Corporation, Bio-Rad Laboratories Inc., Miltenyi Biotec GmbH, Abcam PLC, BioVision Inc., Promega Corporation, Caliper Life Sciences Inc., Cell Signaling Technology Inc., BioTek Instruments Inc., Enzo Life Sciences Inc., BioAgilytix Labs LLC, Cisbio International LLC, ProQinase GmbH, QGel SA, Biotium Inc., Selexis SA, Aurelia Bioscience Ltd., Creative Bioarray, Cell Biolabs Inc., Essen BioScience Ltd., Eurofins Scientific SE, DiscoveRx Corporation

North America was the largest region in the cell-based assays market in 2023. Western Europe was the second largest region in the global cell-based assays market share. The regions covered in the cell based assays market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the cell based assays market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The cell-based assay market consists of sales of reagents, cell lines, microplates, microplates, assay kits, probes, and labels. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Cell Based Assays Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on cell based assays market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for cell based assays ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The cell based assays market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

1) By Product & Service: Consumables; Instruments; Services; Software
2) By Technology: Automated Handling; Flow Cytometry; Label-Free Detection; High-Throughput Screening; Other Technologies
3) By Application: Drug Discovery; Basic Research; ADME Studies; Predictive Toxicology; Other Applications
4) By End User: Pharmaceutical And Biotechnology Companies; Academic And Government Research Institutes; Contract Research Organizations (CRO); Other End Users

Sub-segments

By Instruments: Microplates; Microplate Readers; High Throughput Screening; Liquid Handling Systems
By Consumables: Reagents And Media; Cells And Cell Lines; Probes And Labels
Companies Mentioned: F. Hoffmann-La Roche Ltd.; Merck & Co. Inc.; Thermo Fisher Scientific Inc.; Danaher Corporation; Becton, Dickinson and Company
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

1. Executive Summary

2. Cell Based Assays Market Characteristics

3. Cell Based Assays Market Trends And Strategies

4. Cell Based Assays Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Cell Based Assays Market Size and Growth

5.1. Global Cell Based Assays Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Cell Based Assays Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Cell Based Assays Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Cell Based Assays Market Segmentation

6.1. Global Cell Based Assays Market, Segmentation By Product & Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Consumables
Instruments
Services
Software
6.2. Global Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Automated Handling
Flow Cytometry
Label-Free Detection
High-Throughput Screening
Other Technologies
6.3. Global Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Drug Discovery
Basic Research
ADME Studies
Predictive Toxicology
Other Applications
6.4. Global Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Pharmaceutical And Biotechnology Companies
Academic And Government Research Institutes
Contract Research Organizations (CRO)
Other End Users

7. Cell Based Assays Market Regional And Country Analysis

7.1. Global Cell Based Assays Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Cell Based Assays Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Cell Based Assays Market

8.1. Asia-Pacific Cell Based Assays Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Cell Based Assays Market

9.1. China Cell Based Assays Market Overview
9.2. China Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Cell Based Assays Market

10.1. India Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Cell Based Assays Market

11.1. Japan Cell Based Assays Market Overview
11.2. Japan Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Cell Based Assays Market

12.1. Australia Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Cell Based Assays Market

13.1. Indonesia Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Cell Based Assays Market

14.1. South Korea Cell Based Assays Market Overview
14.2. South Korea Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Cell Based Assays Market

15.1. Western Europe Cell Based Assays Market Overview
15.2. Western Europe Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Cell Based Assays Market

16.1. UK Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Cell Based Assays Market

17.1. Germany Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Cell Based Assays Market

18.1. France Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Cell Based Assays Market

19.1. Italy Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Cell Based Assays Market

20.1. Spain Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Cell Based Assays Market

21.1. Eastern Europe Cell Based Assays Market Overview
21.2. Eastern Europe Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Cell Based Assays Market

22.1. Russia Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Cell Based Assays Market

23.1. North America Cell Based Assays Market Overview
23.2. North America Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Cell Based Assays Market

24.1. USA Cell Based Assays Market Overview
24.2. USA Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Cell Based Assays Market

25.1. Canada Cell Based Assays Market Overview
25.2. Canada Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Cell Based Assays Market

26.1. South America Cell Based Assays Market Overview
26.2. South America Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Cell Based Assays Market

27.1. Brazil Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Cell Based Assays Market

28.1. Middle East Cell Based Assays Market Overview
28.2. Middle East Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Cell Based Assays Market

29.1. Africa Cell Based Assays Market Overview
29.2. Africa Cell Based Assays Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Cell Based Assays Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Cell Based Assays Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Cell Based Assays Market Competitive Landscape And Company Profiles

30.1. Cell Based Assays Market Competitive Landscape
30.2. Cell Based Assays Market Company Profiles
- 30.2.1. F. Hoffmann-La Roche Ltd.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Merck & Co. Inc.
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Thermo Fisher Scientific Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Danaher Corporation
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Becton, Dickinson and Company
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Cell Based Assays Market Other Major And Innovative Companies

31.1. GE HealthCare Technologies Inc.
31.2. Corning Incorporated
31.3. Lonza Group Ltd.
31.4. Charles River Laboratories International Inc.
31.5. PerkinElmer Inc.
31.6. Sigma-Aldrich Corporation
31.7. Bio-Rad Laboratories Inc.
31.8. Miltenyi Biotec GmbH
31.9. Abcam plc
31.10. BioVision Inc.
31.11. Promega Corporation
31.12. Caliper Life Sciences Inc.
31.13. Cell Signaling Technology Inc.
31.14. BioTek Instruments Inc.
31.15. Enzo Life Sciences Inc.

32. Global Cell Based Assays Market Competitive Benchmarking

33. Global Cell Based Assays Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Cell Based Assays Market

35. Cell Based Assays Market Future Outlook and Potential Analysis

35.1 Cell Based Assays Market In 2028 - Countries Offering Most New Opportunities
35.2 Cell Based Assays Market In 2028 - Segments Offering Most New Opportunities
35.3 Cell Based Assays Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies